NAFDAC Orders Production Of Chloroquine For COVID-19 Clinical Trials

The National Agency for Food and Drug Administration and Control (NAFDAC) has ordered the production of Chloroquine for possible clinical trial treatment of Coronavirus.

Prof. Mojisola Adeyeye, the Director-General of the agency gave this directive in a statement on via Channels TV on Monday morning.

Also Read: Ganduje Declares One-Day Fast In Kano, Says Prayer Is The Best Fire Against Coronavirus

She added that it was important to produce more stock just in case more people become exposed to the virus since the drug has shown the possibility of treating the virus in other countries.

The NAFDAC Director called on people not to use the drug without the guidance of a medical doctor or clinician.

She further stated that an abuse of the drug could lead to gastrointestinal upset, blurred vision, headache, and pruritis (itching).